Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma
Author:
Pocasap Piman,
Prawan Auemduan,
Kongpetch SarinyaORCID,
Senggunprai LaddawanORCID